Prevalence of Primary Aldosteronism in Patients With Resistant Hypertension in China

Completed

• Conditions: Hypertension, Resistant to Conventional Therapy

• Registration Number: NCT01459042
• Lead Sponsor: Shanghai Jiao Tong University School of Medicine

Brief Summary

Recent studies indicate that primary aldosteronism (PA) is a much more common cause of hypertension than had been demonstrated historically. In patients with resistant hypertension, the prevalence of PA from different clinics worldwide is about 10-20%. As has been no such data in China, the investigators are conducting a PA study in different province of China to evaluate the prevalence of PA in patients with resistant hypertension.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-01
• Status Verified: 2011-10
• Primary Completion: 2011-10
• Study First Submitted: 2011-10-21
• Study First Submitted QC: 2011-10-24
• Last Update Submitted: 2011-10-24
• Study First Posted: 2011-10-25
• Last Update Posted: 2011-10-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

• patients with resistant hypertension
• age 18-65 years

Exclusion Criteria

• known cause of hypertension
• heart failure
• renal dysfunction
• Stroke, transient ischaemic attack or myocardial infarction in the past 6 months
• cirrhosis
• pregnancy
• undertreatment of glucocorticoid

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Dep.endocrinology of Shanghai Ruijin Hospital, Shanghai Jiaotong university school of medcine; 🇨🇳 Shanghai, Shanghai, China